Finally, as adropin plasma levels in humans are influenced by obesity and dietary preferences (there is a positive association between human serum adropin levels and fat intake and a negative association with carbohydrate intake), liraglutide-induced changes in metabolic profile might be the explanation of this observation [31]. This evidence concerns the gene ENHO and Obesity.